Early trophoblast invasion and placentation in women with different PCOS phenotypes

Reproductive BioMedicine Online

Volumn 29, Issue 3, 2014, Pages 370-381

  Palomba, Stefano ^a   Falbo, Angela ^a   Chiossi, Giuseppe ^a   Tolino, Achille ^b   Tucci, Luigi ^c   La Sala, Giovanni Battista ^a,d   Zullo, Fulvio ^d,e  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c PUGLIESE CIACCIO HOSPITAL   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Insulin resistance; PCOS; Phenotypes; Placentation; Pregnancy; Trophoblast invasion

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; GLUCOSE; INSULIN; PLACENTA PROTEIN 14; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; ASSESSMENT OF HUMANS; BODY MASS; CELL INVASION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FERRIMAN GALLWEY SCORE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PLACENTA WEIGHT; PREGNANCY OUTCOME; REPRODUCTION; SECOND TRIMESTER PREGNANCY; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY; TROPHOBLAST; WAIST HIP RATIO; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY;

ADULT; FEMALE; HUMANS; PHENOTYPE; PLACENTA; PLACENTATION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; TROPHOBLASTS;

EID: 84926201418     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2014.04.010     Document Type: Article

References (54)

1. Ackerman, C.M., Lowe, L.P., Dyer, A.R., Hayes, M.G., Metzger, B.E., Lowe, W.L., Urbanek, M., HAPO Study Co-operative Research Group, 2013. Maternal testosterone levels are associated with C-peptide levels in the Mexican American subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study cohort. Horm. Metab. Res. 45, 617-620.
2. Alok, A., Mukhopadhyay, D., Karande, A.A., 2009. Glycodelin A, an immunomodulatory protein in the endometrium, inhibits proliferation and induces apoptosis in monocytic cells. Int. J. Biochem. Cell Biol. 41, 1138-1147.
3. Apparao, K.B., Lovely, L.P., Gui, Y., Lininger, R.A., Lessey, B.A., 2002. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol. Reprod. 66, 297-304.
4. Aye, I.L., Jansson, T., Powell, T.L., 2013. Interleukin-1β inhibits insulin signaling and prevents insulin-stimulated system A amino acid transport in primary human trophoblasts. Mol. Cell. Endocrinol. 381, 46-55.
5. Cakmak, H., Taylor, H.S., 2011. Implantation failure: molecular mechanisms and clinical treatment. Hum. Reprod. Update 17, 242-253.
6. Cermik, D., Selam, B., Taylor, H.S., 2003. Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88, 238-243.
7. Chinnathambi, V., Balakrishnan, M., Ramadoss, J., Yallampalli, C., Sathishkumar, K., 2013. Testosterone alters maternal vascular adaptations: role of the endothelial NO system. Hypertension 61, 647-654.
8. Diamanti-Kandarakis, E., Dunaif, A., 2012. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33, 981-1030.
9. DuQuesnay, R., Wright, C., Aziz, A.A., Stamp, G.W., Trew, G.H., Margara, R.A., White, J.O., 2009. Infertile women with isolated polycystic ovaries are deficient in endometrial expression of osteopontin but not avβ3 integrin during the implantation window. Fertil. Steril. 91, 489-499.
10. Escobar, J.C., Patel, S.S., Beshay, V.E., Suzuki, T., Carr, B.R., 2011. The human placenta expresses CYP17 and generates androgens de novo. J. Clin. Endocrinol. Metab. 96, 1385-1392.
11. Falbo, A., Rocca, M., Russo, T., D'Ettore, A., Tolino, A., Zullo, F., Orio, F., Palomba, S., 2010. Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes. J. Ovarian. Res. 3, 23.
12. Gonzez, F., 2012. Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids 77, 300-305.
13. Gregory, C.W., Wilson, E.M., Apparao, K.B., Lininger, R.A., Meyer, W.R., Kowalik, A., Fritz, M.A., Lessey, B.A., 2002. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J. Clin. Endocrinol. Metab. 87, 2960-2966.
14. Harville, E.W., Viikari, J.S., Raitakari, O.T., 2011. Preconception cardiovascular risk factors and pregnancy outcome. Epidemiology 22, 724-730.
15. Hodson, K., Man, C.D., Smith, F.E., Thelwall, P.E., Cobelli, C., Robson, S.C., Taylor, R., 2013. Mechanism of insulin resistance in normal pregnancy. Horm. Metab. Res. 45, 567-571.
16. Irwin, J.C., Suen, L.F., Faessen, G.H., Popovici, R.M., Giudice, L.C., 2001. Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGFbinding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation. J. Clin. Endocrinol. Metab. 86, 2060-2064.
17. Jones, H., Sprung, V.S., Pugh, C.J., Daousi, C., Irwin, A., Aziz, N., Adams, V.L., Thomas, E.L., Bell, J.D., Kemp, G.J., Cuthbertson, D.J., 2012. Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. J. Clin. Endocrinol. Metab. 97, 3709-3716.
18. Kajihara, T., Tanaka, K., Oguro, T., Tochigi, H., Prechapanich, J., Uchino, S., Itakura, A., Sucurovic, S., Murakami, K., Brosens, J.J., Ishihara, O., 2014. Androgens modulate the morphological characteristics of human endometrial stromal cells decidualized in vitro. Reprod. Sci. 21, 372-380.
19. Kaňovün N., Bicovün M., 2011. Hyperandrogenic states in pregnancy. Physiol. Res. 60, 243-252.
20. Kjerulff, L.E., Sanchez-Ramos, L., Duffy, D., 2011. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am. J. Obstet. Gynecol. 204, 558.e1-6.
21. Lam, K.K., Chiu, P.C., Lee, C.L., Pang, R.T., Leung, C.O., Koistinen, H., Seppala, M., Ho, P.C., Yeung, W.S., 2011. Glycodelin-A protein interacts with Siglec-6 protein to suppress trophoblast invasiveness by down regulating extracellular signal-regulated kinase (ERK)/c-Jun signaling pathway. J. Biol. Chem. 286, 37118-37127.
22. Langston, C., Kaplan, C., Macpherson, T., Manci, E., Peevy, K., Clark, B., Murtagh, C., Cox, S., Glenn, G., 1997. Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch. Pathol. Lab. Med. 121, 449-476.
23. Maliqueo, M., Bacallao, K., Quezada, S., Clementi, M., Gabler, F., Johnson, M.C., Vega, M., 2007. Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome. Fertil. Steril. 87, 321-328.
24. Maliqueo, M., Lara, H.E., Sanchez, F., Echiburu, B., Crisosto, N., Sir-Petermann, T., 2013. Placental steroidogenesis in pregnant women with plycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 166, 151-155.
25. Marshall, E., Lowrey, J., MacPherson, S., Maybin, J.A., Collins, F., Critchley, H.O., Saunders, P.T., 2011. In silico analysis identifies a novel role for androgens in the regulation of human endometrial apoptosis. J. Clin. Endocrinol. Metab. 96, 1746-1755.
26. Mayama, R., Izawa, T., Sakai, K., Suciu, N., Iwashita, M., 2013. Improvement of insulin sensitivity promotes extravillous trophoblast cell migration stimulated by insulin-like growth factor-I. Endocr. J. 60, 359-368.
27. Mioni, R., Chiarelli, S., Xamin, N., Zuliani, L., Granzotto, M., Mozzanega, B., Maffei, P., Martini, C., Blandamura, S., Sicolo, N., Vettor, R., 2004. Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients. J. Clin. Endocrinol. Metab. 89, 4089-4096.
28. Moro, F., Morciano, A., Tropea, A., Sagnella, F., Palla, C., Scarinci, E., Cosentino, N., Niccoli, G., Liuzzo, G., 2012. CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes. Fertil. Steril. 98, 1609-1615.
29. Orio, F., Palomba, S., 2014. New guidelines for the diagnosis and treatment of PCOS. Nat. Rev. Endocrinol. 10, 130-132.
30. Orio, F., Palomba, S., Cascella, T., De Simone, B., Di Biase, S., Russo, T., Labella, D., Zullo, F., Lombardi, G., Colao, A., 2004. Early impairment of endothelial structure and function in young normalweight women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 89, 4588-4593.
31. Orio, F., Palomba, S., Cascella, T., Di Biase, S., Manguso, F., Tauchmanova, L., Nardo, L.G., Labella, D., Savastano, S., Russo, T., Zullo, F., 2005. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 90, 2-5.
32. Palomba, S., Falbo, A., Russo, T., Tolino, A., Orio, F., Zullo, F., 2010a. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil. Steril. 94, 1805-1811.
33. Palomba, S., Falbo, A., Russo, T., Battista, L., Tolino, A., Orio, F., Zullo, F., 2010b. Uterine blood flow in pregnant patients with polycystic ovary syndrome: relationships with clinical outcomes. BJOG 117, 711-721.
34. Palomba, S., Russo, T., Falbo, A., Di Cello, A., Amendola, G., Mazza, R., Tolino, A., Zullo, F., Tucci, L., La Sala, G.B., 2012. Decidual endovascular trophoblast invasion in women with polycystic ovary syndrome: an experimental case-control study. J. Clin. Endocrinol. Metab. 97, 2441-2449.
35. Palomba, S., Russo, T., Falbo, A., Di Cello, A., Tolino, A., Tucci, L., La Sala, G.B., Zullo, F., 2013. Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome. Hum. Reprod. 28, 2838-2847.
36. Palomba, S., Falbo, A., Chiossi, G., Orio, F., Tolino, A., Colao, A., La Sala, G.B., Zullo F., 2014. Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study. J. Clin. Endocrinol. Metab. doi:10.1210/jc.2014-1214.
37. Panidis, D., Tziomalos, K., Macut, D., Delkos, D., Betsas, G., Misichronis, G., Katsikis, I., 2012. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome. Fertil. Steril. 97, 494-500.
38. Pathak, S., Hook, E., Hackett, G., Murdoch, E., Sebire, N.J., Jessop, F., Lees, C., 2010. Cord coiling, umbilical cord insertion and placental shape in an unselected cohort delivering at term: relationship with common obstetric outcomes. Placenta 31, 963-968.
39. Pathak, S., Sebire, N.J., Hook, L., Hackett, G., Murdoch, E., Jessop, F., Lees, C., 2011. Relationship between placental morphology and histological findings in an unselected population near term. Virchows Arch. 459, 11-20.
40. Pijnenborg, R., Dixon, G., Robertson, W.B., Brosens, I., 1980. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1, 3-19.
41. Prefumo, F., Sebire, N.J., Thilaganathan, B., 2004. Decreased endovascular trophoblast invasion in first trimester pregnancies with high resistance uterine artery Doppler indices. Hum. Reprod. 19, 206-209.
42. Quezada, S., Avellaira, C., Johnson, M.C., Gabler, F., Fuentes, A., Vega, M., 2006. Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome. Fertil. Steril. 85, 1017-1026.
43. Rosas, C., Gabler, F., Vantman, D., Romero, C., Vega, M., 2010. Levels of Rabs and WAVE family proteins associated with translocation of GLUT4 to the cell surface in endometria from hyperinsulinemic PCOS women. Hum. Reprod. 25, 2870-2877.
44. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19-25.
45. Sadek, K.H., Cagampang, F.R., Bruce, K.D., Shreeve, N., Macklon, N., Cheong, Y., 2012. Variation in stability of housekeeping genes in endometrium of healthy and polycystic ovarian syndrome women. Hum. Reprod. 27, 251-256.
46. Salafia, C.M., Yampolsky, M., Shlakhter, A., Mandel, D.H., Schwartz, N., 2012. Variety in placental shape: when does it originate? Placenta 33, 164-170.
47. Samy, N., Hashim, M., Sayed, M., Said, M., 2009. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis. Markers 26, 163-170.
48. Seppala, M., Taylor, R.N., Koistinen, H., Koistinen, R., Milgrom, E., 2002. Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr. Rev. 23, 401-430.
49. Stuebe, A.M., Landon, M.B., Lai, Y., Spong, C.Y., Carpenter, M.W., Ramin, S.M., Casey, B., Wapner, R.J., Varner, M.W., Rouse, D.J., Sciscione, A., Catalano, P., Harper, M., Saade, G., Sorokin, Y., Peaceman, A.M., Tolosa, J.E., Eunice Kennedy Shriver National Institute of Child Health, Human Development Maternal-Fetal Medicine Units Network, Bethesda, MD, 2012. Maternal BMI, glucose tolerance, and adverse pregnancy outcomes. Am. J. Obstet. Gynecol. 207, 62.e1-62.e7.
50. Sun, M., Maliqueo, M., Benrick, A., Johansson, J., Shao, R., Hou, L., Jansson, T., Wu, X., Stener-Victorin, E., 2012. Maternal androgen excess reduces placental and fetal weight, increases placental steroidogenesis, and leads to long-term health effects in their female offspring. Am. J. Physiol. Endocrinol. Metab. 303, 1373-1385.
51. Vrijkotte, T.G., Krukziener, N., Hutten, B.A., Vollebregt, K.C., van Eijsden, M., Twickler, M.B., 2012. Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study. J. Clin. Endocrinol. Metab. 97, 3917-3925.
52. Yildiz, B.O., Bozdag, G., Yapici, Z., Esinler, I., Yarali, H., 2012. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum. Reprod. 27, 3067-3073.
53. Zhao, Y., Fu, L., Li, R., Yang, Y., Liu, N.N., Zhang, C.M., Wang, Y., Liu, P., Tu, B.B., Zhang, X., Qiao, J., 2012. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med. 10, 153.
54. Zhu, X.D., Bonet, B., Knopp, R.H., 1997. 17beta-Estradiol, progesterone, and testosterone inversely modulate low-density lipoprotein oxidation and cytotoxicity in cultured placental trophoblast and macrophages. Am. J. Obstet. Gynecol. 177, 196-209.